Delivery Order SPE2DB25D9320-SPE2DB25FWFCR
- Not listed
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, valued at $12,115.65, was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025. The award carries no set-aside designation and represents a single delivery order issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a delivery order valued at approximately $12.1K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). The contract carries a firm fixed-price structure with no set-aside designation and an ultimate completion date of July 31, 2025. This delivery order was issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $24,293.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). This firm fixed-price delivery order was awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, and carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $60,578.25 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). Issued on August 18, 2025, with an ultimate completion date of August 19, 2025, this firm fixed-price delivery order carries no set-aside designation. The contract represents a specific product draw against DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,115.65 by the Defense Logistics Agency on August 12, 2025, for the supply of Jakafi 10 mg tablets (60-count). This delivery order was issued without a set-aside designation and carries an ultimate completion date of August 13, 2025. The award represents a task order under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,146.79 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Jakafi 5 mg tablets (60-count units). The contract represents a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and was awarded without set-aside designation. This delivery order is issued under DMS Pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,089.78 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-count units). The contract, awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order was executed on August 20, 2025, with an ultimate completion date of August 21, 2025. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open market while...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 20mg tablets (60-count). This firm fixed-price delivery order, valued at $24,179.56, is scheduled for completion by August 25, 2025, and represents a direct purchase under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency. The...
- The Defense Logistics Agency awarded a delivery order valued at $24,179.58 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-count). The award, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a firm fixed-price delivery order with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- SPE2DB25D9320Indefinite Delivery Contract
- SPE2DB25D9320-SPE2DB25FWFCRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $16,285.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, was issued without a set-aside designation. The contract is executed under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which carries a ceiling value of $499.9 million and remains valid through November 2026. This IDC framework enables the agency to procure a comprehensive range of pharmaceutical products to support military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts with the Defense Logistics Agency for branded and generic prescription medications, biologics, and medical consumables. The company leverages its woman-owned small business status to compete effectively in federal procurement markets while maintaining a robust portfolio of pharmaceutical deliveries to Department of Defense healthcare facilities. Jakafi, an FDA-approved medication for myelofibrosis and polycythemia vera, represents the type of specialty pharmaceutical product that supports the medical supply needs of military health systems across the department's global footprint.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.3k | 9/8/25 |